Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapy

The aim of this study was to evaluate if bone marrow (BM) SUVmax measured on pre-treatment 18F-FDG PET/CT predicts the clinical outcome of locally advanced cervical cancer (LACC). We recruited retrospectively patients with LACC who underwent staging 18F-FDG PET/CT and had baseline blood tests, then...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Oncoimmunology
المؤلفون الرئيسيون: Seban, Romain-David, Robert, Charlotte, Dercle, Laurent, Yeh, Randy, Dunant, Ariane, Reuze, Sylvain, Schernberg, Antoine, Sun, Roger, Mignot, Fabien, Terroir, Marie, Schlumberger, Martin, Haie-Meder, Christine, Chargari, Cyrus, Deutsch, Eric
التنسيق: Artigo
اللغة:Inglês
منشور في: Taylor & Francis 2019
الموضوعات:
Original Research
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC6492982/
https://ncbi.nlm.nih.gov/pubmed/31069132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2019.1574197
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة